Prosecution Insights
Last updated: October 04, 2026

Gates & Cooper LLP - Minimed

Technology area: Medical Devices & Mechanical Engineering

5 pending office actions • 1 client • 3 examiners • 1 art unit • 0 of 5 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days

Analysis

Gates & Cooper LLP - Minimed handles patent matters in the Medical Devices & Mechanical Engineering technology area. The firm is associated with 34213 career applications, reflecting a large historical volume of work. This scale of 34213 applications suggests institutional knowledge of the patent prosecution process. There are currently 5 pending office actions for this specific profile.

The firm maintains a resolved allowance rate of 84.55 percent. This rate is achieved with an average of 3.82 office actions per allowance. In the Medical Devices & Mechanical Engineering field, this 3.82 average indicates a prosecution process that often requires multiple rounds of negotiation and amendment to reach a grant. The 84.55 percent allowance rate shows an ability to eventually secure patent rights.

The 5 pending office actions represent the current active cases under this profile. The 34213 career applications provide a broad context for the firm's 84.55 percent success rate. Clients can evaluate the 3.82 average office actions per allowance as a measure of the persistence and effort typically required to overcome examiner rejections in this technical space.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=34213 apps, methodology: how we score firms)

84.6%
Allowance Rate
n=34213
+0.65σ
Allowance Rate (norm)
n=34213
3.8
OAs to Allowance
n=20667
+0.03σ
OAs to Allow (norm)
n=20667
1082 days
Time to Allowance
n=20667
+8.9pp
Interview Lift
n=34213
32.5%
RCE Rate
n=34213
2.7%
Appeal Rate
n=34213

Rejection Performance (% of received rejections ultimately overcome)

76.2%
§101 Overcome
n=2437
77.2%
§102 Overcome
n=9011
77.9%
§103 Overcome
n=15242
77.9%
§112 Overcome
n=10440

Specialization & Scale

A61K, H01M, G06F
Top CPC Subclasses
13%
Top-3 CPC Share
n=34213
90
Practitioners
n=34213
380.1
Apps / Practitioner
n=34213

Portfolio Summary

5
Total Pending OAs
1
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (20%)
4
Medium (80%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (20%)
§103 only3 (60%)
Double-patenting + other1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
5
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ROZANSKI, GRACE NMN 3 60.5% +20.7%
CATINA, MICHAEL ANTHONY 1 31.5% +30.3%
CHEN, TSE W 1 55.0% +25.4%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18763620 IMPLANTABLE POLYMER SURFACES EXHIBITING REDUCED IN VIVO INFLAMMATORY RESPONSES CATINA, MICHAEL ANTHONY —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18666596 INTERFERENCE REJECTION MEMBRANES USEFUL WITH ANALYTE SENSORS ROZANSKI, GRACE NMN 3d overdue
18366299 SENSORS FOR 3-HYDROXYBUTYRATE DETECTION ROZANSKI, GRACE NMN 21d
18763620 IMPLANTABLE POLYMER SURFACES EXHIBITING REDUCED IN VIVO INFLAMMATORY RESPONSES CATINA, MICHAEL ANTHONY —
18344273 ACRYLATE HYDROGEL MEMBRANE FOR DUAL FUNCTION OF DIFFUSION LIMITING MEMBRANE AS WELL AS ATTENUATION TO THE FOREIGN BODY RESPONSE ROZANSKI, GRACE NMN —
18296198 REDUCING SENSOR FOREIGN BODY RESPONSE VIA HIGH SURFACE AREA METAL STRUCTURES CHEN, TSE W —

Client Portfolio (1 client)

Client (Assignee)Pending OAs
MEDTRONIC MINIMED, INC. 5

Top Art Units

Art UnitApps
37915

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18763620 IMPLANTABLE POLYMER SURFACES EXHIBITING REDUCED IN VIVO INFLAMMATORY RESPONSES Medtronic Minimed, Inc. CATINA, MICHAEL ANTHONY 3791 §101§103Other Non-Final OA — Pending Jul 03, 2024
18666596 INTERFERENCE REJECTION MEMBRANES USEFUL WITH ANALYTE SENSORS Medtronic Minimed, Inc. ROZANSKI, GRACE NMN 3791 §103 Final Rejection 3d overdue Pending May 16, 2024
18366299 SENSORS FOR 3-HYDROXYBUTYRATE DETECTION Medtronic Minimed, Inc. ROZANSKI, GRACE NMN 3791 §103 Final Rejection 21d Pending Aug 07, 2023
18344273 ACRYLATE HYDROGEL MEMBRANE FOR DUAL FUNCTION OF DIFFUSION LIMITING MEMBRANE AS WELL AS ATTENUATION TO THE FOREIGN BODY RESPONSE Medtronic Minimed, Inc. ROZANSKI, GRACE NMN 3791 §103 Final Rejection — Pending Jun 29, 2023
18296198 REDUCING SENSOR FOREIGN BODY RESPONSE VIA HIGH SURFACE AREA METAL STRUCTURES Medtronic Minimed, Inc. CHEN, TSE W 3791 §102§103§112DP Final Rejection — Pending Apr 05, 2023

Managing Gates & Cooper LLP - Minimed's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month